Evidence brief: Use of intradialytic parenteral nutrition (IDPN) to treat malnutrition in hemodialysis patients

Chronic kidney disease (CKD) is a major public health concern, affecting 14.8% of US adults in 2011-2014, and was the 9th leading cause of death in the US in 2016. Progression of CKD leads to end-stage renal disease (ESRD), a total and permanent failure of kidney function requiring kidney transplant...

Full description

Bibliographic Details
Main Authors: Anderson, Johanna, Peterson, Kim (Author), Bourne, Donald (Author), Boundy, Erin (Author)
Corporate Authors: United States Department of Veterans Affairs, Portland VA Medical Center Evidence-based Synthesis Program Center, Quality Enhancement Research Initiative (U.S.)
Format: eBook
Language:English
Published: Washington, DC Department of Veterans Affairs, Health Services Research And Development Service 2018, March 2018
Series:Evidence-based synthesis program
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 02765nam a2200325 u 4500
001 EB002072219
003 EBX01000000000000001212309
005 00000000000000.0
007 tu|||||||||||||||||||||
008 220923 r ||| eng
100 1 |a Anderson, Johanna 
245 0 0 |a Evidence brief: Use of intradialytic parenteral nutrition (IDPN) to treat malnutrition in hemodialysis patients  |h Elektronische Ressource  |c prepared for Department of Veterans Affairs, Veterans Health Administration, Quality Enhancement Research Initiative, Health Services Research And Development Service ; prepared by Evidence-Based Synthesis Program (ESP) Coordinating Center, Portland VA Medical Center ; investigators, Johanna Anderson, Kim Peterson, Donald Bourne, Erin Boundy 
246 3 1 |a IDPN for malnutrition in hemodialysis 
246 3 1 |a Use of intradialytic parenteral nutrition (IDPN) to treat malnutrition in hemodialysis patients 
260 |a Washington, DC  |b Department of Veterans Affairs, Health Services Research And Development Service  |c 2018, March 2018 
300 |a 1 PDF file (i, 27 pages)  |b illustrations 
505 0 |a Includes bibliographical references 
700 1 |a Peterson, Kim  |e [author] 
700 1 |a Bourne, Donald  |e [author] 
700 1 |a Boundy, Erin  |e [author] 
710 2 |a United States  |b Department of Veterans Affairs 
710 2 |a Portland VA Medical Center  |b Evidence-based Synthesis Program Center 
710 2 |a Quality Enhancement Research Initiative (U.S.) 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
490 0 |a Evidence-based synthesis program 
500 |a At head of title: QUERI. 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK518608  |3 Volltext 
082 0 |a 610 
520 |a Chronic kidney disease (CKD) is a major public health concern, affecting 14.8% of US adults in 2011-2014, and was the 9th leading cause of death in the US in 2016. Progression of CKD leads to end-stage renal disease (ESRD), a total and permanent failure of kidney function requiring kidney transplant or maintenance hemodialysis. More than half (63.1%) of all prevalent ESRD cases receive hemodialysis, and despite its advantages, hemodialysis patients often suffer poor health outcomes, including substantially worse survival rates than the general population. The most recent systematic review from 2010 concluded that data at that time were insufficient to definitively determine the benefit of IDPN.47 However, since 2010, 3 new randomized controlled trials have emerged. The objective of this evidence brief is to synthesize the evidence regarding the effectiveness, harms, and cost-effectiveness of using intradialytic parenteral nutrition (IDPN) in hemodialysis patients with malnutrition